Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
AstraZeneca’s lung cancer drug approved in Japan
July 2, 2018 Off

AstraZeneca’s lung cancer drug approved in Japan

By Dino Mustafić

AstraZeneca and MedImmune, its global biologics research and development arm, today announced that the Japanese Ministry of Health, Labour and…

CHMP recommends approval of Sanofi’s Cablivi
June 29, 2018 Off

CHMP recommends approval of Sanofi’s Cablivi

By Dino Mustafić

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Cablivi (caplacizumab) in Europe…

Novartis aims at spinoff of Alcon eye care devices business
June 29, 2018 Off

Novartis aims at spinoff of Alcon eye care devices business

By Dino Mustafić

Novartis on Friday said it intends to spinoff Alcon, its eye care division, into a separately-traded standalone company, which would…

Sanofi and Advent in negotiations for €1.9 billion acquisition of Zentiva
June 28, 2018 Off

Sanofi and Advent in negotiations for €1.9 billion acquisition of Zentiva

By Dino Mustafić

Sanofi and Advent International have finished negotiations for the acquisition of Zentiva, Sanofi’s European generics business, by Advent and the…

Better prevention can curbe significant disruption to daily life and work caused by migraine
June 28, 2018 Off

Better prevention can curbe significant disruption to daily life and work caused by migraine

By Dino Mustafić

Novartis and the European Migraine and Headache Alliance (EMHA) Wednesday presented initial findings from the largest global migraine patient study…

June 27, 2018 Off

Lynparza significantly delays disease progression in Phase III 1st-line SOLO-1 trial for ovarian cancer

By Dino Mustafić

AstraZeneca and Merck’s Phase III SOLO-1 trial of Lynparza (olaparib) tablets, for women with BRCA-mutated (BRCAm) advanced ovarian cancer treated…

June 27, 2018 Off

Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market

By Dino Mustafić

Symcel said Wednesday it has appointed two new board members; Erik Walldén and Stefan Löfås, who are expected to play a…

Servier, Galapagos kick off therapeutic candidate phase 2 trial for knee osteoarthritis patients
June 27, 2018 Off

Servier, Galapagos kick off therapeutic candidate phase 2 trial for knee osteoarthritis patients

By Dino Mustafić

Servier  and Galapagos NV have started a global Phase 2 trial with S201086/GLPG1972 in knee osteoarthritis patients, titled Roccella, in…

Long way for psoriasis patients despite clear or almost clear skin being more achievable
June 26, 2018 Off

Long way for psoriasis patients despite clear or almost clear skin being more achievable

By Dino Mustafić

The impact of psoriasis is more than skin deep and can have a profound effect on people’s physical and emotional…

Former TiGenix CEO to lead Nordic Nanovector from July
June 25, 2018 Off

Former TiGenix CEO to lead Nordic Nanovector from July

By Dino Mustafić

Nordic Nanovector has appointed Vivet Therapeutic’s chairman and former TiGenix’s CEO, Eduardo Bravo as its new Chief Executive Officer, the…

Posts pagination

Previous 1 … 3,384 3,385 3,386 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine